uploads///virus _

What Analysts Recommend for AbbVie and Peers in March 2018

By

Mar. 29 2018, Updated 3:13 p.m. ET

Company overview

AbbVie (ABBV) is a global biopharmaceutical company with a focus on research. It develops and markets advanced rheumatology, gastroenterology, dermatology, oncology, and virology therapies. Its products also target neurological disorders like Parkinson’s disease and multiple sclerosis. AbbVie’s pipeline also includes medicines for cystic fibrosis and women’s health.

Article continues below advertisement

Analyst recommendations

Of the 23 analysts covering AbbVie in March 2018, four analysts have given the stock a “strong buy” rating, and six analysts have given it a “buy” rating. 12 analysts have given Abbvie a “hold” rating while one analyst has given it a “sell” rating. The mean rating for the stock is 2.4 with a target price of $125.9.

Peer ratings

Of the 33 analysts covering Biogen (BIIB) in March 2018, 24 analysts have given the stock a “buy” or higher rating, while nine analysts have given it a “hold” rating. The mean rating for the stock is two with a target price of $378.9.

Of the six analysts covering Xencor (XNCR) in March 2018, three analysts have given the stock a “strong buy” rating and two analysts have given it a “buy” rating, while one analyst has given it a “hold” rating. The mean rating for the stock is 1.7 with a target price of $36.67.

Of the eight analysts covering Novavax (NVAX) in March 2018, two analysts have given the stock a “strong buy” rating and one analyst has given it a “buy” rating. Four analysts have given Novavax a “hold” rating, while one analyst has given it a “sell” rating. The mean rating for the stock is 2.5 with a target price of $3.83.

In the next part of the series, we’ll take a look at the product portfolio of AbbVie.

Advertisement

More From Market Realist

  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.